Právní předpis byl sestaven k datu 14.05.2026.
Zobrazené znění právního předpisu je účinné od 07.12.2020.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2021
509/2020 Sb.
509
SDĚLENÍ
Ministerstva xxxxxxxxxxxxx
xx dne 18. xxxxxxxxx 2020
x xxxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx xxx 2021
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. e) zákona x. 258/2000 Xx., x xxxxxxx veřejného xxxxxx a x xxxxx některých xxxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, stanoví xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx komise xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx pro xxx 2021:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx očkování
1a) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX):
Xx xxxxxxxxxxxx 1 dávka (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx1 xx xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (IU)
Tetani anatoxinum1 xx méně xxx 40 xxxxxxxxxxxxx jednotek (XX)
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx (XX)1 25 xxxxxxxxxx
Xxxxxxxxx haemagglutininum xxxxxxxxxxxx (XXX)1 25 mikrogramů
Pertactinum (XXX)1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx hepatitidis X (XXx)2,3 10 mikrogramů
Virus xxxxxxxxxxxxxxx inactivatum (IPV)
typus 1 (xxxx Xxxxxxx)4 40 D xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)4 8 X xxxxxxxx antigenu
typus 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx b xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 10 xxxxxxxxxx
xxxx. xxx xxxxxx. xxxxxxxx xxxx xxxxx xxxxxxx xxxxxxxxx 25 xxxxxxxxxx
1 adsorbováno xx xxxxxxxx xxxxxxx, xxxxxxxxxxx (Xx(XX)3) 0,5 miligramů Xx3+
2 xxxxxxxx xxxxxxxxxxxxx XXX technologií na xxxxxxx kvasinkových xxxxx (Xxxxxxxxxxxxx xxxxxxxxxx)
3 adsorbováno xx fosforečnan xxxxxxx (XxXX4) 0,32 xxxxxxxxx Xx3+
4 xxxxxxxxx na XXXX xxxxxxx
XXXX
1xx) kombinovaná xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx b (XXxXXxxXXXXXX)
Xxxxx xxxxx1 (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx xx xxxx xxx 20 xxxxxxxxxxxxx jednotek (XX)2
Xxxxxx xxxxxxxxxx xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx anatoxinum 25 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Xxxxxxx) 40 X jednotek antigenu4
typus 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx4
xxxxx 3 (Saukett) 32 X xxxxxxxx xxxxxxxx4
Xxxxxxxxx xxxxxxxxx hepatitidis X5 10 mikrogramů
Polyribosylribitoli xxxxxxxx xxxxxxxxxx xxxxxxxxxx B 12 mikrogramů
(Polyribosylribitoli xxxxxxxx)
xxxxxxxxx xxx tetani anatoxinum 22-36 xxxxxxxxxx
1 adsorbováno xx xxxxxxxxxxx hydroxid xxxxxxx (0,6 xx Xx3+)
2 xxxx xxxxxx xxx xxxxxxxxxxxxx (x = 0,95)
3 xxxxxxxxx xx XXXX xxxxxxx
4 xxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxx stanovené xxxxxxx xxxxxxxxxxxxxx xxxxxxx
5 vyrobeno xxxxxxxxxxxxx XXX xxxxxxxxxxx x xxxxxxxxxxxx buňkách Xxxxxxxxx xxxxxxxxxx
XXXX
1xx) Xxxxxxx xxxxx difterii, xxxxxx, xxxxxxx (xxxxxxxxx komponenta), xxxxxxxxxx B (rDNA), xxxxxxxxxxxxxx (xxxxxxxxxxxx) a xxxxxxxxxxx xxxxxxx xxxxx Xxxxxxxxxxx xxxx x (xxxxxxxxxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum1 xx méně xxx 20 XX
Xxxxxx anatoxinum1 xx méně než 40 XX
Xxxxxxxx Xxxxxxxxxxx xxxxxxxx1
Xxxxxxxxx anatoxinum (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 20 mikrogramů
Pertactinum (XXX) 3 xxxxxxxxxx
Xxxxxxxx xxxx 2 et 3 (XXX) 5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx hepatitidis X2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (xxxxxxxxxxx)4
Xxxxx 1 (Xxxxxxx) 40 D xxxxxxxx antigenu5
Typus 2 (XXX-1) 8 D xxxxxxxx xxxxxxxx5
Xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx xxxxxxxx5
Xxxxxxxxxxxxxx Xxxxxxxxxx xxxxxxxxxx xxxxx x
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 3 mikrogramy xxxxxxxxxx cum xxxxxxxxx xxxxxxxxxxxx xxxxx b2 50 xxxxxxxxxx
1 adsorbováno xx fosforečnan hlinitý (0,17 xx Xx3+)
2 xxxxxxxxxxx xx hydratovaný xxxxxxxx xxxxxxx xxxxxx (0,15 xx Al3+)
3 xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx v xxxxxxxxxxxx xxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx
4 xxxxxxxxx xx Xxxx xxxxxxx
5 nebo xxxxxxxxxxxx xxxxxxxx antigenu xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx.
1x) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), xxxxxx (XXxX):
Xxxxx xxxxx (0,5 xx) xxxxxxxx tyto xxxxxx xxxxx:
Xxxxxxxxxxx anatoxinum* ≥ 30 XX
Xxxxxx xxxxxxxxxx* ≥ 40 XX
Xxxxxxxxx xxxxxxxxxx* (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx* (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx* (69xX) 8 xxxxxxxxxx
* xxxxxxxxxxx na xxxxxxxx xxxxxxx xxxxxx: 0,5 xxxxxxxxx
XXXX
1xx) Xxxxxxxx xxxxx proti záškrtu, xxxxxx x dávivému xxxxx (xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx - Minimálně 2 XX* (2 Lf)
Tetani xxxxxxxxxx - Minimálně 20 IU* (5 Xx)
Xxxxxxxxx antigeny
Pertussis xxxxxxxxxx - 2,5 mikrogramu
Haemagglutinum xxxxxxxxxxxx - 5 xxxxxxxxxx
Xxxxxxxxxxx - 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx hlinitý - 1,5 xx (0,33 xx xxxxxxx)
* Xxxx xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx xxxxx testu xxxxxxxxx x Xxxxxxxxx xxxxxxxx.
XXXX
1xx) Xxxxxxxx látka proti xxxxxxx, tetanu x xxxxxxxx xxxxx (acelulární xxxxxxxxxx) xx sníženým xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx anatoxinum1 xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 xx xxxx než 20 mezinárodních jednotek (XX) (5 Lf)
Bordetellae xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 mikrogramů
Pertussis xxxxxxxxx xxxxxxx xxxxxxxxx1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx hydroxid xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Al3+ x xxxxxxxxxxx xxxxxxx (XxXX4) 0,2 xxxxxxxxx Xx3+
1x) xxxxxxxx látka proti xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx x:
Xxxxx xxxxx lyofilizované xxxxxxx xxxxxxxx:
Xxxxxxxxxxxxxxx Xxx purificatum (10 mikrogramů) cum Xxxxxxxxx xxxxxxxx (přibližně 25 mikrogramů).
1d) očkovací xxxxx xxxxx xxxxxx:
Xxxxx xxxxx obsahuje:
Tetani anatoxinum - xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B v xxxxxx formuli:
Jedna xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 10 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx virové hepatitidě X v xxxxxxx xxxxxxx
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B - 20 xxxxxxxxxx
1x) xxxxxxxx xxxxx proti xxxxxxxxxx, příušnicím a xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Schwarz) xxx. 103,0 xxxxxxxx xxxxx xxx buněčnou xxxxxxx503
Xxxxxxxxxxx xxxxx attenuatum1 (XXX 4385) xxx. 103,7 infekční xxxxx xxx xxxxxxxx kulturu503
Rubeolae xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 infekční xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx buňkách xxxxxxxx xxxxxx
2 pomnoženo xx xxxxxxxx xxxxxxxxxxx xxxxxxx (MRC-5)
3 50 % xxxxxxxx dávka xxxxxxx xxxxxxx
XXXX
1xx) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx obsahuje xxxxx xxxxx (0,5 ml):
Virus xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx xxxx než 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxx XxxxXX, hladina X) ne méně xxx 12,5x103 CCID50*
Virus xxxxxxxx2 xxxxx xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx méně xxx 1x103 XXXX50*
* 50 % infekční xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx na xxxxxxx xxxxxxxx xxxxxx.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx XX-38 xxxxxxxxxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxx obrně x inaktivované xxxxx:
Xxxxx xxxxx obsahuje:
Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) … 40 xxxxxxxxxxx X jednotek*
Virus xxxxxxxxxxxxx inactivatum xxxxx 2 (MEF-1) ......… 8 antigenních X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Saukett) ...… 32 antigenních X xxxxxxxx*
* nebo xxxxxxxx xxxxxxxxxxxxxx antigenů xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.
1xx) xxxxxxxx xxxxx konjugovaná xxxxx xxxxxxxxxxxxx infekcím:
Jedna xxxxx xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 11 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 31 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 41 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 51 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X1 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 6X1 4,4 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 141 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 18X1 2,2 µx
Xxxxxxxxxxxx pneumoniae polysaccharidum xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 19F1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X1 2,2 µx
1 Xxxxxxxxxx s xxxxxx proteinem XXX197, xxxxxxxxxx na fosforečnan xxxxxxx.
Xxxxx xxxxx (0,5xx) xxxxxxxx xxxxxxxxx 32 µx nosného xxxxxxxx XXX197 a 0,125 xx xxxxxxx.
1x) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum1 - xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 - xx xxxx než 20 xxxxxxxxxxxxx jednotek (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx anatoxinum1 - 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 - 8 mikrogramů
Pertaktin1 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (kmen Xxxxxxx)2 - 40 D xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx MEF-1)2 - 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (kmen Xxxxxxx)2 - 32 X xxxxxxxx xxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx hlinitý (Al(OH)3) 0,3 miligramu Al3+ x fosforečnan hlinitý (XxXX4) 0,2 xxxxxxxxx Xx3+
2 xxxxxxxxx xx XXXX xxxxxxx
XXXX
1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum xxxxxxxxx 2 XX* (2,5 Lf)
Tetani xxxxxxxxxx xxxxxxxxx 20 XX* (5 Lf)
Pertusové xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx 2,5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx 5 xxxxxxxxxx
Xxxxxxxxxxx 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3 5 mikrogramů
Virus xxxxxxxxxxxxxxx (xxxxxxxxxxx)**
xxxxx 1 40 D xxxxxxxx xxxxxxxx
xxxxx 2 8 X xxxxxxxx xxxxxxxx
xxxxx 3 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx na xxxxxxxxxxx xxxxxxx 1,5 xx (0,33 mg xxxxxxx)
* Xxxx spodní xxxxxxx xxxxxxxxx spolehlivosti (x = 0,95) xxxxxxxx měřené xxxxx xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx.
** Xxxxxxxxxxx xx Xxxx xxxxxxx.
1x) xxxxxxxx látka xxxxx xxxxxxxxxxx (XXX xxxxxxx)
1x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X xxx xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:
Xxxxx xxxxx (0,5 xx) xxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X1,2,3 - 20 xxxxxxxxxx
1 adjuvovaný xx XX04X xxxxxxxxxx: - 3-X-xxxxxx-4'-xxxxxxxxxxxx-xxxxx X (XXX)2 50 xxxxxxxxxx
2 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (xxxxxx 0,5 xxxxxxxxx Xx3+)
3 xxxxxxxx xx xxxxxxx xxxxxxxxxxxx xxxxx (Saccharomyces xxxxxxxxxx) xxxxxxxxxxxxx DNA technologií.
2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro zvláštní xxxxxxxx
2x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx tegiminis hepatitidis X - 20 xxxxxxxxxx
2x) xxxxxxxx látka xxxxx vzteklině
2c) xxxxxxxx xxxxx proti virové xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx spalničkám, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 infekční xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx attenuatum1 (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx kulturu503
Rubeolae virus xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx xx xxxxxxxx diploidních buňkách (XXX-5)
3 50 % xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
2xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx jedna xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx xxxx xxx 1x103 XXXX50*
Xxxxx parotitidis1 xxxxx xxxxxxxxxx (xxxx Jeryl Xxxx™, hladina X) xx méně než 12,5x103 CCID50*
Virus xxxxxxxx2 xxxxx xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50 % infekční xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx xx buňkách xxxxxxxx xxxxxx
2 xxxxxxxx na xxxxxxxx diploidních xxxxxxxx XX-38 fibroblastech
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx mimořádná xxxxxxxx
3x) xxxxxxxx látka proti xxxxxx hepatitidě A xx xxxxxxx xxx xxxxxxx:
Xxxxxxxxx X virus xxxxxxxxxxx
3x) očkovací xxxxx xxxxx virové xxxxxxxxxx X xx xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx virus xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx kulturu503
Parotitidis xxxxx xxxxxxxxxx1 (RIT 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Wistar XX 27/3) xxx. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3 50 % xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
3xx) xxxxxxxx látka xxxxx spalničkám, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 ml):
Virus morbillorum1 xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx xxxx xxx 1x103 XXXX50*
Xxxxx parotitidis1 vivum xxxxxxxxxx (kmen Xxxxx XxxxXX, hladina B) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 xxxxx xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx méně xxx 1x103 XXXX50*
* 50 % xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx xx xxxxxxx kuřecích xxxxxx
2 xxxxxxxx na xxxxxxxx xxxxxxxxxxx xxxxxxxx XX-38 xxxxxxxxxxxxx.
Xxxxxxx:
xxx. XXXx. Xxxxxx, Xx.X., v. x.
Informace
Právní xxxxxxx č. 509/2020 Xx. xxxxx xxxxxxxxx dnem 7.12.2020.
Xx xxx uzávěrky právní xxxxxxx xxxxx xxxxx xx doplňován.
Znění jednotlivých xxxxxxxx norem jiných xxxxxxxx xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se jich xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.